| Subjects | Responsea (%) | Trialb | ||||||||||||
| ID | Age | Sex | HA | LA | MA | CE | HA | LA | MA | CE | ||||
| (W1) | (W2) | (W1) | (W2) | |||||||||||
| 1 | 38 | F | 23 | 6 | 1 | 0 | 0 | 1 - 5, 7 - 18, | 6, 19, 20, | 28 | − | − | ||
| (76.7) | (20.0) | (3.3) | 21 - 23, 25 - 27 | 24, 29, 30 | ||||||||||
| 2 | 39 | M | 24 | 3 | 1 | 1 | 1 | 1 - 3, 5, 6, 8 - 16, | 4, 17, 21 | 7 | 20 | 23 | ||
| (80.0) | (10.0) | (3.3) | (3.3) | 18, 19, 22, 24 - 30 | ||||||||||
| 3 | 29 | F | 18 | 9 | 2 | 1 | 0 | 1 - 7, 10 - 13, | 8, 14, | 9, 26 | 15 | − | ||
| (60.0) | (30.0) | (6.7) | (3.3) | 16 - 18, 23 - 25, 27 | 19 - 22, 28 - 30 | |||||||||
| 4 | 29 | M | 24 | 4 | 1 | 0 | 1 | 1 - 3, 5 - 15, | 16, 21, | 4 | − | 23 | ||
| (80.0) | (13.3) | (3.3) | 17 - 20, 22, 24 - 28 | 29, 30 | ||||||||||
| 5 | 30 | F | 22 | 6 | 2 | 0 | 0 | 1 - 6, 8, 10 - 13, 15, | 7, 14, 16, | 9, 17 | − | − | ||
| (73.3) | (20.0) | (6.7) | 18 - 21, 23, 25 - 27, 29, 30 | 22, 24, 28 | ||||||||||
| 6 | 30 | M | 27 | 2 | 1 | 0 | 0 | 1 - 20, 22 - 28 | 29, 30 | 21 | − | − | ||
| (90.0) | (6.7) | (3.3) | ||||||||||||
| 7 | 28 | F | 21 | 6 | 2 | 1 | 0 | 1 - 8, 11 - 18, | 9, 10, 19, | 22, 28 | 25 | − | ||
| (70.0) | (20.0) | (6.7) | (3.3) | 20, 23, 24, 26, 27 | 21, 29, 30 | |||||||||
| 8 | 27 | F | 25 | 2 | 2 | 1 | 0 | 1 - 7, 9, 10, 12 - 15, | 21, 29 | 11, 16 | 8 | − | ||
| (83.3) | (6.7) | (6.7) | (3.3) | 17 - 20, 22 - 28, 30 | ||||||||||
| 9 | 44 | F | 23 | 7 | 0 | 0 | 0 | 1 - 8, 10, 12 - 21, | 9, 11, 22, | − | − | − | ||
| (76.7) | (23.3) | 23, 24, 26, 27 | 25, 28 - 30 | |||||||||||
| 10 | 28 | M | 28 | 2 | 0 | 0 | 0 | 1, 3 - 28, 30 | 2, 29 | − | − | − | ||
| (93.3) | (6.7) | |||||||||||||
| 11 | 32 | M | 25 | 4 | 1 | 0 | 0 | 1, 3 - 13, 15 - 26, 30 | 2, 14, | 27 | − | − | ||
| (83.3) | (13.3) | (3.3) | 28, 29 | |||||||||||
| 12 | 33 | M | 27 | 2 | 0 | 0 | 1 | 1 - 22, 24 - 27, 30 | 28, 29 | − | − | 23 | ||
| (90.0) | (6.7) | |||||||||||||